Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2004 Jul;9(3):221-36.
doi: 10.1023/B:JOMG.0000048770.90334.3b.

The genetic epidemiology of breast cancer genes

Deborah Thompson  1 , Douglas Easton
Affiliations
Free article
Review

The genetic epidemiology of breast cancer genes

Deborah Thompson et al. J Mammary Gland Biol Neoplasia. .
Free article
Favorites

Abstract

Genetic susceptibility to breast cancer in women is conferred by a large number of genes, of which six have so far been identified. In the context of multiple-case families, BRCA1 and BRCA2 are the most important. Mutations in these genes confer high lifetime risks of breast cancer and ovarian cancer, and more moderate risks of prostate cancer and some other cancer types. Mutations in the CHEK2 and ATM genes, by contrast, cause much more modest (2-4 fold) risks of breast cancer. Genes so far identified explain approximately 20% of the familial aggregation of breast cancer. The remaining susceptibility genes have, so far, proved illusive, suggesting that they are numerous and confer moderate risks. A variety of techniques including genome-wide association studies, use of quantitative intermediate endpoints, and resequencing of genes may be required to identify them. The identification of such genes can provide a basis for targeted prevention of breast cancer.

Similar articles

See all similar articles

Cited by 66 articles

See all "Cited by" articles

References

    1. JAMA. 1998 Mar 25;279(12):922-9 - PubMed
    1. Breast Cancer Res Treat. 2000 Jan;59(2):185-92 - PubMed
    1. J Mol Med (Berl). 1997 Oct;75(10):758-61 - PubMed
    1. Am J Hum Genet. 1995 Jan;56(1):265-71 - PubMed
    1. J Clin Oncol. 2000 Dec 15;18(24):4053-9 - PubMed

Publication types

MeSH terms

Feedback